inews.co.uk on MSN

Wegovy on the NHS ends after 24 months – meaning weight gain or going private

The arrival of Wegovy two years ago caused turmoil in health services around the world ...

European Regulator Backs Approval Of Novo Nordisk High-Dose Wegovy

EMA issues positive opinion on Novo Nordisk's higher-dose Wegovy, supported by strong weight-loss data and ongoing reviews in ...

Novo’s High-Dose Wegovy Gets Green Light From EU Drug Panel

Novo Nordisk A/S said its high-dose version of blockbuster Wegovy has been cleared by the European Union’s drug advisory board, opening the way for use of a shot that delivers more weight loss than ...

Hims & Hers: The Market's Panic Is Irrational

Hims & Hers Health has sold off ~40% GLP-1 turbulence, but the core growth story remains intact. Read why HIMS stock is a ...

EU drugs regulator backs higher dose of Novo's Wegovy

Novo Nordisk said on Friday the European Medicines Agency's committee has issued a positive opinion for a 7.2 mg dose of weight-loss drug Wegovy, providing an option for greater weight loss.